Benz R L, Teehan B P, Sigler M H, Gilgore G S, Schleifer C R
Division of Nephrology, Lankenau Hospital, Lankenau Medical Research Center, Wynnewood, PA.
Am J Kidney Dis. 1991 Dec;18(6):649-54. doi: 10.1016/s0272-6386(12)80604-4.
Renal arteriography with concomitant renal vein renin profiling remains the diagnostic standard for evaluating the anatomic and physiologic significance of stenotic renal artery lesions in hypertensive patients. False-negative renal vein renin profiles with failure of lateralization in patients with anatomically apparent high-grade stenosis complicate the diagnostic process. Mannitol is frequently administered prophylactically to minimize the risk of dye nephropathy in these patients. Yet, the potential effects of mannitol on renal vein renin profiling in man have not been previously reported. Seven patients with renovascular hypertension were studied prospectively to determine changes in renal vein renin profiles before and after mannitol prophylaxis. Despite captopril stimulation, all patients demonstrated significant renin suppression leading to the loss of renin lateralization in patients with unilateral renovascular hypertension. In 60% of the patients, renal vein renin ratios fell to below the standard 1.5 to 1 ratio after mannitol infusion. In patients with bilateral renovascular disease, the least stenotic side suppressed completely, while the more stenotic side suppressed partially. Percent suppression analysis showed a mean suppression of 56.8% on the stenotic side versus 8.2% on the noninvolved side (P less than 0.002). In every study, suppression equaled or exceeded 32% on the involved side and was less than this on the noninvolved side. Thus, the degree of renin suppression following mannitol infusion may prove to be an important tool in the diagnosis of clinically significant stenotic lesions. The mechanism of mannitol-induced suppression remains undefined, but appears independent of volume expansions or dilutional effects. The inhibitory effects of mannitol on renin profiles can obscure the diagnosis of underlying renovascular hypertension.
肾动脉造影术联合肾静脉肾素分析仍是评估高血压患者狭窄性肾动脉病变的解剖学和生理学意义的诊断标准。对于解剖学上明显存在高度狭窄的患者,肾静脉肾素分析出现假阴性且缺乏侧别差异,这使诊断过程变得复杂。在这些患者中,经常预防性使用甘露醇以将造影剂肾病的风险降至最低。然而,甘露醇对人体肾静脉肾素分析的潜在影响此前尚未见报道。对7例肾血管性高血压患者进行了前瞻性研究,以确定预防性使用甘露醇前后肾静脉肾素分析的变化。尽管使用了卡托普利刺激,但所有患者均表现出显著的肾素抑制,导致单侧肾血管性高血压患者肾素侧别差异消失。60%的患者在输注甘露醇后肾静脉肾素比值降至标准的1.5比1以下。在双侧肾血管疾病患者中,狭窄程度较轻的一侧肾素完全被抑制,而狭窄程度较重的一侧部分被抑制。抑制百分比分析显示,狭窄侧平均抑制率为56.8%,未受累侧为8.2%(P<0.002)。在每项研究中,受累侧的抑制率等于或超过32%,未受累侧则低于此值。因此,输注甘露醇后肾素的抑制程度可能是诊断具有临床意义的狭窄性病变的重要工具。甘露醇诱导抑制的机制尚不清楚,但似乎与容量扩张或稀释效应无关。甘露醇对肾素分析的抑制作用可能会掩盖潜在肾血管性高血压的诊断。